Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Nutr Biochem ; 26(2): 165-72, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25468613

ABSTRACT

High-density lipoproteins (HDLs) are atheroprotective because of their role in reverse cholesterol transport. The intestine is involved in this process because it synthesizes HDL, removes cholesterol from plasma and excretes it into the lumen. We investigated the role of selected dietary fatty acids on intestinal cholesterol uptake and HDL functionality. Caco-2 monolayers grown on Transwells were supplemented with either palmitic, palmitoleic, oleic, linoleic, docosahexaenoic, eicosapentaenoic, arachidonic or conjugated linoleic acids (CLAs): c9,t11-CLA; t9,t11-CLA; c10,t12-CLA. Cells synthesized HDL in the basolateral compartment for 24 h in the absence or presence of an antibody to SR-BI (aSR-BI), which inhibits its interaction with HDL. Free cholesterol (FC) accumulated to a greater extent in the presence than in the absence of aSR-BI, indicating net uptake of FC by SR-BI. Uptake's efficiency was significantly decreased when cells were treated with c9,t11-CLA relative to the other fatty acids. These differences were associated with lower HDL functionality, since neither SR-BI protein expression nor expression and alternative splicing of other genes involved lipid metabolism were affected. Only INSIG2 expression was decreased, with no increase of its target genes. Increasing pre-ß-HDL synthesis, by inducing ABCA1 and adding APOA1, resulted in reduced uptake of FC by SR-BI after c9,t11-CLA treatment, indicating reduced functionality of pre-ß-HDL. Conversely, treatment with c9,t11-CLA resulted in a greater uptake of FC and esterified cholesterol from mature HDL. Therefore, Caco-2 monolayers administered c9,t11-CLA produced a nonfunctional pre-ß-HDL but took up cholesterol more efficiently via SR-BI from mature HDL.


Subject(s)
Cholesterol, Dietary/metabolism , Cholesterol, HDL/metabolism , Enterocytes/metabolism , Enterohepatic Circulation , Intestinal Absorption , Linoleic Acids, Conjugated/metabolism , Lipoproteins, HDL/metabolism , Alternative Splicing , Biological Transport , CD36 Antigens/antagonists & inhibitors , CD36 Antigens/genetics , CD36 Antigens/metabolism , Caco-2 Cells , Cell Polarity , Cholesterol Esters/metabolism , Cholesterol, HDL/blood , Enterocytes/cytology , Gene Expression Regulation , High-Density Lipoproteins, Pre-beta/genetics , High-Density Lipoproteins, Pre-beta/metabolism , Humans , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Kinetics , Lipoproteins, HDL/blood , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/genetics , Membrane Proteins/metabolism , Stereoisomerism
2.
J Nutr ; 144(5): 575-85, 2014 May.
Article in English | MEDLINE | ID: mdl-24623846

ABSTRACT

Consumption of the long-chain ω-3 (n-3) polyunsaturated fatty acid docosahexaenoic acid (DHA) is associated with a reduced risk of cardiovascular disease and greater chemoprevention. However, the mechanisms underlying the biologic effects of DHA remain unknown. It is well known that microRNAs (miRNAs) are versatile regulators of gene expression. Therefore, we aimed to determine if the beneficial effects of DHA may be modulated in part through miRNAs. Loss of dicer 1 ribonuclease type III (DICER) in enterocyte Caco-2 cells supplemented with DHA suggested that several lipid metabolism genes are modulated by miRNAs. Analysis of miRNAs predicted to target these genes revealed several miRNA candidates that are differentially modulated by fatty acids. Among the miRNAs modulated by DHA were miR-192 and miR-30c. Overexpression of either miR-192 or miR-30c in enterocyte and hepatocyte cells suggested an effect on the expression of genes related to lipid metabolism, some of which were confirmed by endogenous inhibition of these miRNAs. Our results show in enterocytes that DHA exerts its biologic effect in part by regulating genes involved in lipid metabolism and cancer. Moreover, this response is mediated through miRNA activity. We validate novel targets of miR-30c and miR-192 related to lipid metabolism and cancer including nuclear receptor corepressor 2, isocitrate dehydrogenase 1, DICER, caveolin 1, ATP-binding cassette subfamily G (white) member 4, retinoic acid receptor ß, and others. We also present evidence that in enterocytes DHA modulates the expression of regulatory factor X6 through these miRNAs. Alteration of miRNA levels by dietary components in support of their pharmacologic modulation might be valuable in adjunct therapy for dyslipidemia and other related diseases.


Subject(s)
Docosahexaenoic Acids/pharmacology , Dyslipidemias/genetics , Enterocytes/drug effects , Lipid Metabolism/drug effects , MicroRNAs/metabolism , ATP Binding Cassette Transporter, Subfamily G , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Caco-2 Cells , Caveolin 1/genetics , Caveolin 1/metabolism , Co-Repressor Proteins/genetics , Co-Repressor Proteins/metabolism , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/metabolism , Dyslipidemias/metabolism , Enterocytes/physiology , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/physiology , Hep G2 Cells , Humans , Isocitrate Dehydrogenase/genetics , Isocitrate Dehydrogenase/metabolism , Lipid Metabolism/genetics , RNA, Small Interfering/genetics , Receptors, Retinoic Acid/genetics , Receptors, Retinoic Acid/metabolism , Ribonuclease III/genetics , Ribonuclease III/metabolism
3.
J Agric Food Chem ; 62(10): 2228-32, 2014 Mar 12.
Article in English | MEDLINE | ID: mdl-24559192

ABSTRACT

Although polyphenols are often merely perceived as antioxidants, their biological activities are manifold and include anti-inflammatory actions. A new area of research on polyphenols and health concerns their putative role in cholesterol metabolism, in particular, their high-density lipoprotein-cholesterol (HDL-c)-raising potential. Indeed, some human studies showed that administration of polyphenol-rich foods such as cocoa, green tea, and extra virgin olive oil modulate and increase HDL-c concentrations. This study assessed the effects of polyphenols on intestinal inflammation, using the physiologically relevant Caco-2 Transwell model and using lipopolysaccharide (LPS) to trigger inflammation. This study also investigated the mechanisms of actions behind the proposed HDL-c-increasing effects of polyphenols. The data suggest that polyphenols (at least those from red wine, cocoa, and green tea) administered at a dietary dose moderately modulate intestinal inflammation but do not increase cholesterol secretion by intestinal cells or enhance HDL functionality. Nutraceuticals and supplements provide pharmanutritional doses that might, conversely, produce beneficial effects.


Subject(s)
Cacao/chemistry , Camellia sinensis/chemistry , Gastroenteritis/drug therapy , Lipoproteins, HDL/metabolism , Polyphenols/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Caco-2 Cells/drug effects , Caco-2 Cells/metabolism , Cholesterol, HDL/metabolism , Humans , Interleukin-6/metabolism , Lipopolysaccharides/pharmacology , Wine
4.
Springerplus ; 3: 41, 2014.
Article in English | MEDLINE | ID: mdl-24498581

ABSTRACT

BACKGROUND: The single nucleotide polymorphism (SNP) rs7903146 (C/T), located in intron 4 of the transcription factor 7-like 2 gene (TCF7L2), has been associated with an increased risk of developing Type 2 Diabetes, although the molecular mechanism remain elusive. The TCF7L2 gene is alternatively spliced but an association between genotype and splice variants has not been shown convincingly. We hypothesized that a yet unknown extra exon, containing either the C or T genotype of the SNP rs7903146, could introduce a premature stop codon and consequently result in nonsense-mediated decay (NMD). FINDINGS: Running the sequences C and T of the SNP region in different servers we found that the two alleles could display differential recognition by splicing factors. The C variant showed the possible inclusion of an unknown exon. This unknown exon contained a stop codon and thus could induce NMD. We then determined that the splicing pattern in isolated mouse islets and MIN6 cells was similar to that in human pancreatic islets. Therefore, we used MIN6 cells to study the splicing of human intron 4: two mini-genes of intron 4 containing either the C/C genotype or the T/T genotype were transfected into MIN6 cells. Our constructs were spliced normally, excluding intron 4, but we did not observe the presence of an extra exon with either construct. CONCLUSIONS: We found that an extra exon could theoretically exist, although we were not able to capture it in our model. A better model is needed to determine whether a theoretical extra exon can induce NMD.

5.
Mol Nutr Food Res ; 58(5): 954-62, 2014 May.
Article in English | MEDLINE | ID: mdl-24347345

ABSTRACT

SCOPE: Hydroxytyrosol (HT) is a phenolic compound peculiarly abundant in olives and it is being recognized as a protector of LDL from oxidation. In addition to lipid oxidation, one emerging risk factor for cardiovascular disease is ER stress. We tested the effect of HT on the modulation of ER stress in HepG2 cells. METHODS AND RESULTS: HepG2 cells were treated with 1 µM and 5 µM of HT and 100 µM lipoic acid (LA) and glutathione-ethyl ester (GSH), for 24 h. Induction of the unfolded protein response (UPR) was initiated by treatment with 2 µg/mL tunicamycin for 4 h. Real time RT-PCR analyses followed by Western blot and ELISA of different ER stress markers revealed that the protective activities of HT were superior to those of two known thiolic antioxidants, i.e., LA and GSH. CONCLUSION: Mounting evidence indicates the ER as an important target of dietary or pharmacological intervention. In this paper, we report the modulatory activities of physiological concentrations of HT toward ER stress and we shed some light on pathways alternative to the well-known antioxidant mechanisms, through which olive oil phenolics modulate cell signaling and could impact cardiovascular health and degenerative diseases.


Subject(s)
Carcinoma, Hepatocellular/pathology , Endoplasmic Reticulum Stress/drug effects , Phenylethyl Alcohol/analogs & derivatives , Tunicamycin/adverse effects , Antioxidants/pharmacology , Carcinoma, Hepatocellular/metabolism , Glutathione/analogs & derivatives , Glutathione/pharmacology , Hep G2 Cells , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Lipid Metabolism/drug effects , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Olea/chemistry , Olive Oil , Phenols/pharmacology , Phenylethyl Alcohol/pharmacology , Plant Extracts/pharmacology , Plant Oils/chemistry , Risk Factors , Signal Transduction , Thioctic Acid/pharmacology , Unfolded Protein Response
6.
J Nutr ; 143(10): 1565-72, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23946344

ABSTRACT

The aim of this study was to characterize the pathways of basolateral secretion of common dietary tocopherols from polarized Caco-2 monolayers, a model of intestinal absorption. Given differences in structure and physical properties, we hypothesized that secretion may differ between different forms of vitamin E, thus potentially contribute to the selectivity seen in vivo. Monolayers were incubated apically and simultaneously with 10 µmol/L α-, γ-, and δ-tocopherol (1:1:1) in lipid micelles. Treatment with the microsomal triglyceride transfer protein inhibitor BMS201038 revealed that the triglyceride-rich particle secretory pathway (apolipoprotein B-dependent pathway) accounted for ~ 80% of total tocopherol secretion, without selectivity among the three forms of vitamin E. Apolipoprotein B-independent secretion of tocopherols (and cholesterol) was greatly enhanced by the liver X receptor agonist T0901317. T0901317 induced ATP-binding cassette transporter A1 (ABCA1) protein expression and basolateral secretion of tocopherols to apolipoprotein A1. ABCA1-dependent secretion demonstrated vitamer selectivity such that efficiency of secretion of α- and γ-tocopherols exceeded that of δ-tocopherol. Basal addition of HDL stimulated vitamin E secretion but without selectivity among the three forms, whereas LDL had no effect. Basal addition of scavenger receptor class B member I (SR-BI) blocking antibody, which inhibits the interaction between SR-BI and HDL, increased basal accumulation of all tocopherols, demonstrating a role for SR-BI in cellular re-uptake of secreted vitamin E. These findings demonstrated that vitamin E and cholesterol utilize common pathways of secretion and that secretion via the ABCA1 pathway favors certain forms of vitamin E.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , Apolipoprotein A-I/metabolism , Cholesterol/metabolism , Intestinal Mucosa/metabolism , Lipoproteins, HDL/metabolism , Tocopherols/metabolism , Vitamin E/metabolism , Anticholesteremic Agents/pharmacology , Benzimidazoles/pharmacology , Caco-2 Cells , Carrier Proteins/metabolism , Humans , Hydrocarbons, Fluorinated/pharmacology , Intestinal Absorption , Liver X Receptors , Micelles , Models, Biological , Orphan Nuclear Receptors/metabolism , Scavenger Receptors, Class B/metabolism , Sulfonamides/pharmacology
7.
Front Physiol ; 3: 42, 2012.
Article in English | MEDLINE | ID: mdl-22393325

ABSTRACT

Essential fatty acids cannot be synthesized de novo by mammals and need to be ingested either with the diet or through the use of supplements/functional foods to ameliorate cardiovascular prognosis. This review focus on the molecular targets of omega 3 fatty acids and conjugated linoleic acid, as paradigmatic molecules that can be exploited both as nutrients and as pharmacological agents, especially as related to cardioprotection. In addition, we indicate novel molecular targets, namely microRNAs that might contribute to the observed biological activities of such essential fatty acids.

8.
Obes Res ; 13(2): 306-11, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15800288

ABSTRACT

OBJECTIVE: In healthy lean individuals, changes in insulin sensitivity occurring as a consequence of a 2-day dexamethasone administration are compensated for by changes in insulin secretion, allowing glucose homeostasis to be maintained. This study evaluated the changes in glucose metabolism and insulin secretion induced by short-term dexamethasone administration in obese women. RESEARCH METHODS AND PROCEDURES: Eleven obese women with normal glucose tolerance were studied on two occasions, without and after 2 days of low-dose dexamethasone administration. A two-step hyperglycemic clamp (7.5 and 10 mM glucose) with 6,6 (2)H(2) glucose was used to assess insulin secretion and whole body glucose metabolism. Results were compared with those obtained in a group of eight lean women. RESULTS: Without dexamethasone, obese women had higher plasma insulin concentrations in the fasting state, during the first phase of insulin secretion, and at the two hyperglycemic plateaus. However, they had normal whole body glucose metabolism compared with lean women, indicating adequate compensation. After dexamethasone, obese women had a 66% to 92% increase in plasma insulin concentrations but a 15.4% decrease in whole body glucose disposal. This contrasted with lean women, who had a 91% to 113% increase in plasma insulin concentrations, with no change in whole body glucose disposal. DISCUSSION: Dexamethasone administration led to a significant reduction in whole body glucose disposal at fixed glycemia in obese but not lean women. This indicates that obese women are unable to increase their insulin secretion appropriately.


Subject(s)
Dexamethasone/administration & dosage , Glucose/metabolism , Insulin/metabolism , Obesity/physiopathology , Adult , Blood Glucose/analysis , Deuterium , Female , Glucose Clamp Technique , Humans , Hydrocortisone/blood , Insulin/blood , Insulin Secretion , Lipid Peroxidation , Oxidation-Reduction
9.
Obes Res ; 11(5): 625-31, 2003 May.
Article in English | MEDLINE | ID: mdl-12740452

ABSTRACT

OBJECTIVE: Insulin resistance is observed in individuals with normal glucose tolerance. This indicates that increased insulin secretion can compensate for insulin resistance and that additional defects are involved in impaired glucose tolerance or type 2 diabetes. The objective of this study was to evaluate a procedure aimed at assessing the compensatory mechanisms to insulin resistance. RESEARCH METHODS AND PROCEDURES: Eight healthy nonobese female patients were studied on two occasions, before and after administration of 2 mg/d dexamethasone for 2 days during a two-step hyperglycemic clamp. Insulin secretion was assessed from plasma insulin concentrations. Insulin sensitivity was assessed from the ratio of whole-body glucose use (6,6 (2)H(2) glucose) to plasma insulin concentrations. This procedure is known to induce a reversible impairment of glucose tolerance and insulin resistance. RESULTS: In all subjects, dexamethasone induced a decrease in insulin sensitivity and a proportionate increase in first-phase insulin secretion and in insulin concentrations at both steps of glycemia. The resulting hyperinsulinemia allowed the restoration of normal whole-body glucose uptake and the suppression of plasma free fatty acids and triglycerides. In contrast, the suppression of endogenous glucose production was impaired after dexamethasone (p < 0.01). DISCUSSION: Increased insulin secretion fully compensates dexamethasone-induced insulin resistance in skeletal muscle and adipose tissue but not in the liver. This suggests that failure to overcome hepatic insulin resistance can impair glucose tolerance. The compensatory insulin secretion in response to insulin resistance can be assessed by means of a hyperglycemic clamp after a dexamethasone challenge.


Subject(s)
Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Glucose/metabolism , Insulin Resistance/physiology , Insulin/metabolism , Adult , Blood Glucose/metabolism , Fatty Acids, Nonesterified/blood , Female , Glucagon/blood , Glucose Clamp Technique , Glucose Tolerance Test , Humans , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...